Method for the treatment nlrp3-associated diseases
AssigneeSofthale NV
InventorsJuergen Rawert, Jan-Torsten Tews
Life of this patent
Estimating the term…
Abstract
The present invention provides for a method for the treatment of a NLRP3-associated disease or condition in a subject, the method comprising the step of administering to said subject a medically active liquid in nebulized form by inhalation, wherein the medically active liquid comprises a NLRP3 inhibitor and wherein the medically active liquid is administered in nebulized form using an inhalation device.
Claims29
A method for the treatment or prevention of a NLRP3-associated disease, disorder or condition in a subject, the method comprising the step of administering to said subject a medically active liquid in nebulized form by inhalation,
- wherein the medically active liquid comprises a NLRP3 inhibitor and wherein the medically active liquid is administered to the subject in nebulized form by inhalation using an inhalation device.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.